Cell Therapy News Volume 23.21 | Jun 20 2022

    0
    43







    2022-06-20 | CTN 23.21


    Cell Therapy News by STEMCELL Technologies
    Vol. 23.30 – 20 June, 2022
    TOP STORY

    Memory-Like NK Cells Armed with a Neoepitope-Specific CAR Exhibit Potent Activity against NPM1 Mutated Acute Myeloid Leukemia

    Researchers showed that arming cytokine-induced memory-like natural killer cells with a neoepitope-specific CAR significantly enhanced their antitumor responses to nucleophosphmin-1 (NPM1)-mutated acute myeloid leukemia while avoiding off-target toxicity.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Abstract
    This webinar provides insights and techniques for efficient leukopak sample processing and streamlined cell isolation.
    PUBLICATIONSRanked by the impact factor of the journal

    Peripheral Blood Immune Cell Profiling of Acute Corneal Transplant Rejection

    In a multi-site, cross-sectional study, clinical details and blood samples were collected from adults with clinically-diagnosed acute rejection of full thickness-corneal transplants (CT) and posterior lamellar-CT along with Stable CT recipients and adults with non-transplanted corneal disease.
    [American Journal of Transplantation]

    Abstract

    Dual-Binding Nanoparticles Improve the Killing Effect of T Cells on Solid Tumor

    Investigators constructed a nanoplatform termed dual-binding magnetic nanoparticles that comprised PEG-maleimide, hyaluronic acid and Fe3O4 for adoptive T cell-modification and adoptive cell therapy-sensitization.
    [Journal of Nanobiotechnology]

    Full Article

    Intravenously Transplanted Mesenchymal Stromal Cells: A New Endocrine Reservoir for Cardioprotection

    Mesenchymal stem cell were isolated from human placenta tissue, and DF-MSCs or Gluc-MSCs were generated by transduced with firefly luciferase/enhanced green fluorescence protein or Gaussia luciferase lactadherin fusion protein.
    [Stem Cell Research & Therapy]

    Full Article

    Human Umbilical Cord-Derived Mesenchymal Stem Cells Not Only Ameliorate Blood Glucose but Also Protect Vascular Endothelium from Diabetic Damage through a Paracrine Mechanism Mediated by MAPK/ERK Signaling

    Researchers conducted in vivo experiment on streptozotocin-induced diabetic rat model to test body weight, fasting blood glucose, serum ICAM-1 and VCAM-1 levels, histopathology and immunohistochemical staining of aorta segments.
    [Stem Cell Research & Therapy]

    Full Article

    Mesenchymal Stem Cells Exert Their Anti-Asthmatic Effects through Macrophage Modulation in a Murine Chronic Asthma Model

    Scientists evaluated the anti-asthmatic effects of mesenchymal stem cells primed with Liproxstatin-1, a potent ferroptosis inhibitor.
    [Scientific Reports]

    Full Article

    Development of Secretome-Based Strategies to Improve Cell Culture Protocols in Tissue Engineering

    The effects of three different types of secretome derived from human mesenchymal stem cells were evaluated on cultured skin epithelial cells during 24, 48, 72 and 120 hours to determine the potential of this product to enhance cell proliferation and improve biofabrication strategies for tissue engineering.
    [Scientific Reports]

    Full Article

    Thirty-Year Clinical Outcomes after Hematopoietic Stem Cell Transplantation in Neuronopathic Gaucher Disease

    In the nine patients reported, neurological disease continued to progress after transplantation, manifesting as seizures, cerebellar disease and abnormalities of tone and reflexes.
    [Orphanet Journal of Rare Diseases]

    Full Article
    Survey results on the insights and hurdles of CRISPR genome editing.
    REVIEWS

    The Cellular Composition and Function of the Bone Marrow Niche after Allogeneic Hematopoietic Cell Transplantation

    Investigators summarize current knowledge on the cellular composition of the human bone marrow niche after hematopoietic cell transplantation.
    [Bone Marrow Transplantation]

    Abstract

    Cell Therapy in Corneal Endothelial Disease

    The authors review the latest developments in cell therapy for corneal endothelial disease, highlighting the work of several groups that have reported successful functional outcomes of cell therapy in animal models.
    [Current Opinion in Ophthalmology]

    Abstract
    INDUSTRY AND POLICY NEWS

    Disgraced Italian Surgeon Convicted of Criminal Harm to Stem Cell Patient

    A surgeon who just a decade ago was celebrated around the globe as a pioneer in stem cell transplants has been convicted of one count of “causing bodily harm,” a felony, in a Swedish court.
    [ScienceInsider]

    Press Release

    Taking Charge—Biotechs Already Approaching Novartis to Partner on ‘Game Changing’ CAR-T Platform

    It shouldn’t be a surprise that biotechs have already been in touch with Novartis to see whether they can jump onto the Swiss pharma’s T-Charge platform.
    [Fierce Biotech]

    Press Release
    FEATURED EVENT

    Immuno US

    October 3 – 4, 2022
    San Diego, California, United States

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Research Scientist – Skin Cancer

    Columbia University – New York City, New York, United States

    Postdoctoral Fellow – Interorgan Crosstalk

    Washington University School of Medicine – St. Louis, Missouri, United States

    Faculty – Hematopoietic Stem Cells

    New York Blood Center – New York, New York, United States

    Postdoctoral Fellow – Tumor Microenvironment

    University of California, San Francisco – San Francisco, California, United States

    Group Leader – Stem Cell Science

    University of Cambridge – Cambridge, England, United Kingdom

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Cell Therapy News Twitter